By Admin at 5 Jan 2016
Unfortunately, only about 20 percent of ovarian cancers are currently detected in the early stages. A new blood test may change that, however, according to a study by researchers at the Georgia Institute of Technology.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
